Recent Quotes

My Watchlist

Indicators

Quanterix Corporation - Common Stock (NQ:QTRX)

4.640 -1.090 (-19.02%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 13, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	2,717,151
Open	5.720
Bid (Size)	4.700 (1)
Ask (Size)	4.760 (11)
Prev. Close	5.730
Today's Range	4.202 - 5.800
52wk Range	4.202 - 19.18
Shares Outstanding	38,063,618
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Quanterix Releases Financial Results for the First Quarter of 2025

May 12, 2025

From Quanterix Corporation

Via Business Wire

Earnings Scheduled For May 12, 2025

May 12, 2025

Via Benzinga

Performance

YTD	-56.9%	-56.9%
1 Month	-17.1%	-17.1%
3 Month	-41.1%	-41.1%
6 Month	-69.4%	-69.4%
1 Year	-72.5%	-72.5%

More News

Earnings Outlook For Quanterix

May 09, 2025

Via Benzinga

Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025

May 05, 2025

From Quanterix Corporation

Via Business Wire

Kent Lake Issues Statement on Quanterix’s Blatant Disregard for Will of Shareholders

April 30, 2025

From Kent Lake PR LLC

Via Business Wire

This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

April 30, 2025

Via Benzinga

Visa To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday

April 30, 2025

Via Benzinga

Quanterix and Akoya Biosciences Announce Amended Merger Agreement

April 29, 2025

From Quanterix Corporation

Via Business Wire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, AKYA, CKPT, QTRX on Behalf of Shareholders

April 17, 2025

From Halper Sadeh LLC

Via GlobeNewswire

Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders

April 17, 2025

From Kent Lake PR LLC

Via Business Wire

Kent Lake Comments on Quanterix’s Value Destructive Bridge Financing for Financially Troubled Akoya

April 07, 2025

From Kent Lake PR LLC

Via Business Wire

Quanterix Showcases Innovation Powered by Simoa® at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit

April 01, 2025

From Quanterix Corporation

Via Business Wire

Goldman Sachs To Rally Around 8%? Here Are 10 Top Analyst Forecasts For Tuesday

March 25, 2025

Via Benzinga

Quanterix Releases Financial Results for the Fourth Quarter of 2024

March 17, 2025

From Quanterix Corporation

Via Business Wire

Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today’s Earnings Call

March 17, 2025

From Kent Lake PR LLC

Via Business Wire

Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results

March 17, 2025

From Akoya Biosciences, Inc.

Via GlobeNewswire

Earnings Scheduled For March 17, 2025

March 17, 2025

Via Benzinga

Quanterix To Report Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025

March 13, 2025

From Quanterix Corporation

Via Business Wire

Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix’s Proposed Merger with Akoya Biosciences

March 11, 2025

From Kent Lake PR LLC

Via Business Wire

Kent Lake Nominates Three Highly Qualified, Independent Candidates for Quanterix Board

March 03, 2025

From Kent Lake PR LLC

Via Business Wire

Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition

March 03, 2025

From Quanterix Corporation

Via Business Wire

Bragar Eagel & Squire, P.C. Is Investigating Quanterix, e.l.f. Beauty, and Silvaco and Encourages Investors to Contact the Firm

February 24, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Company’s Proposed Merger with Akoya Biosciences

February 18, 2025

From Kent Lake PR LLC

Via Business Wire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IVAC, AVTE, QTRX on Behalf of Shareholders

February 17, 2025

From Halper Sadeh LLC

Via GlobeNewswire

Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

February 14, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Frequently Asked Questions

Is Quanterix Corporation - Common Stock publicly traded?

Yes, Quanterix Corporation - Common Stock is publicly traded.

What exchange does Quanterix Corporation - Common Stock trade on?

Quanterix Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Quanterix Corporation - Common Stock?

The ticker symbol for Quanterix Corporation - Common Stock is QTRX on the Nasdaq Stock Market

What is the current price of Quanterix Corporation - Common Stock?

The current price of Quanterix Corporation - Common Stock is 4.640

When was Quanterix Corporation - Common Stock last traded?

The last trade of Quanterix Corporation - Common Stock was at 05/13/25 04:00 PM ET

What is the market capitalization of Quanterix Corporation - Common Stock?

The market capitalization of Quanterix Corporation - Common Stock is 176.62M

How many shares of Quanterix Corporation - Common Stock are outstanding?

Quanterix Corporation - Common Stock has 177M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.